Editorial Board

Carl Allen, MD, PhD
Baylor College of Medicine, Houston, TX

• Lymphoma
• Histiocytic disorders
• Immune dysregulation disorders

Marie Bleakley, MD, PhD, MMSC
Fred Hutchinson Cancer Center, Seattle, WA

• Transplantation
• Cell therapy
• Immunotherapy

Claudia Lengerke, MD
University Hospital Tübingen, Tübingen, Germany

• Stem cells
• Hematopoiesis
• Myeloid malignancies

Georg Lenz, MD
University Clinic Münster, Münster, Germany

• Clinical trials in malignant lymphomas
• Diffuse large B-cell lymphoma
• Oncogenic signaling

Deepa Manwani, MD
The Children's Hospital at Montefiore
and Albert Einstein College of Medicine, Bronx, NY

• Red Cells/Anemia
• Sickle Cell Anemia
• Clinical iron overload
• Hemoglobinopathies

Shannon L. Maude, MD, PhD
Children's Hospital of Philadelphia, Philadelphia, PA

• Immunobiology
• Adoptive cellular therapies, Neoplasia
• Lymphoid Leukemias
• Marrow and stem transplantation

Ryan D. Morin, PhD
Simon Fraser University, Burnaby, Canada

• Neoplasia
• Lymphoma
• Lymphoproliferative conditions

Olatoyosi Odenike, MD
University of Chicago Medicine, Chicago, IL

• Lymphoma
• Histiocytic disorders
• Immune dysregulation disorders

Margaret V. Ragni, MD, MPH
University of Pittsburgh, Pittsburgh, PA

• Bleeding disorders
• Coagulation defects
• Thromboembolism

Noopur Raje, MD
Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA

• Neoplasia
• Myeloma and other plasma cell dyscrasias
• Drug resistance

Constantine Tam, MBBS, MD
Alfred Health and Monash University, East Melbourne, Australia

• CLL
• Lymphoma
• CAR-T therapy

Geoffrey L. Uy, MD
Washington University School of Medicine, St. Louis, MO

• Acute leukemia
• Myelodysplastic syndrome
• Hematopoietic cell transplantation

Alisa S. Wolberg, PhD
University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC

• Hemostasis
• Thrombosis

Anjali Advani, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, United States (Acute lymphoblastic leukemia, Acute myeloid leukemia, Clinical trials)
A Samer Al-Homsi, Northwell Health Cancer Institute and Feinstein Institutes of Medical Research, New Hyde Park, NY, United States (GvHD prevention, allogeneic transplantation)
Sarit Assouline, McGill University, Montreal, Canada (acute leukemia, CLL and B cell lymphomas)
Vera Ulrike Bacher, University Hospital Inselspital, Bern, Switzerland (Acute leukemias, chronic myeloid malignancies, hematologic diagnostics)
Glaivy Batsuli, Stanford University, Palo Alto, CA, United States (coagulation and classical hematology)
Elisabeth M. Battinelli, Brigham and Women’s Hospital, Boston, MA, United States
Lisa Baumann Kreuziger, Versiti Blood Center of Wisconsin, Milwaukee, WI, United States (Classical Heme)
Silvia Beà, IDIBAPS, Barcelona, Spain (B-Cell Lymphoid Neoplasms, Genetic Alterations, Mantle Cell Lymphoma)
Francesco Bertoni, Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland (Lymphoma)
Brian Betts, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States (Transplant immunology, BMT)
Eric Boilard, Centre de Recherche du CHU de Québec-Université Laval, Quebec, Canada (platelet and megakaryocyte biology, autoimmunity)
Andrew Brunner, Massachusetts General Hospital, Boston, MA, United States (Myelodysplastic syndromes, Acute myeloid leukemia, Myeloid neoplasia)
Rena Buckstein, Odette Cancer Center, Toronto, Canada
Robert Campbell, Washington University School of Medicine, Saint Louis, MO, United States (platelets, inflammation, and thrombosis)
Caitlin Costello, University of California San Diego, San Diego, CA, United States (Multiple Myeloma, Systemic Amyloidosis, Transplant and Cellular Therapy)
Robert Cronin, The Ohio State University, Columbus, OH, United States (Sickle cell disease)
Miguel Cruz, Baylor College of Medicine, Houston, TX, United States (von Willebrand factor, platelet adhesion)
Claire Dearden, The Royal Marsden and The Institute of Cancer Research, London, UK (CLL, Hairy cell leukaemia and T cell leukaemias)
Benjamin Derman, University of Chicago Medical Center, Chicago, IL, United States (Multiple myeloma, MRD)
Elie Dib, Trinity Health IHA Medical Group, Hematology Oncology, Ypsilanti, MI, United States (Genomic Medicine, Immuno-oncology, CLL (Chronic Lymphocytic Leukemia)
Courtney Fitzhugh, National Institute of Health, Bethesda, MD, United States (Sickle cell disease, Hematopoietic cell transplant, Clonal hematopoiesis)
Maria Gomes da Silva, Portuguese Institute of Oncology, Lisboa, Portugal (Lymphomas, Lymphoma Treatment, Immunotherapy)
Steven Grant, Virginia Commonwealth University, Richmond, VA, United States (myeloma, AML, signal transduction, apoptosis)
Gabriela Hobbs, Massachusetts General Hospital, Boston, MA, United States (Myeloproliferative neoplasms, Chronic myeloid leukemia, acute leukemia, clinical trials)
Daniel Hodson, University of Cambridge, Cambridge, UK (Lymphoma Biology or Lymphoma Genomics)
Elias Jabbour, MD Anderson Cancer Center, Houston, TX, United States
Nitin Jain, MD Anderson Cancer Center, Houston, TX, United States (CLL, ALL, CAR-T)
Nathalie Johnson, McGill University, Montreal, Canada (Lymphoma, CLL)
Tapan Kadia, University of Texas MD Anderson Cancer Center, Houston, TX, United States (Neoplasia - Lymphoid Leukemias, Myeloid Leukemias and Dysplasias)
Colm Keane, Princess Alexandra Hospital, Brisbane, Australia (Immunobiology, Lymphoid Leukemias, Lymphomas)
Amy Kirkwood, University College London, London, United Kingdom (Statistics and Clinical trials)
Barbara Konkle, University of Washington, Seattle, WA, United States (Inherited bleeding disorders, Acquired bleeding disorders, gene therapy)
Motoko Koyama, Fred Hutchinson Cancer Research Center, Seattle, WA, United States (Transplant and cell therapy, immunology)
Andrew Leavitt, University of California San Francisco, San Francisco, CA, United States (classical heme, hemophilia, bleeding disorders)
Robert Lee, UNC School of Medicine, Chapel Hill, NC, United States (platelets and hemostasis)
Steven Lentz, The University of Iowa Carver College of Medicine, Iowa City, IA, United States (Coagulation, Thrombosis, Platelets)
Kate Markey, The Fred Hutchinson Cancer Research Center, Seattle, WA, United States (Transplant immunology, the microbiome)
Lucia Masarova, MD Anderson Cancer Center, Houston, TX, United States (Myeloproliferative neoplasms (essential thrombocythemia, polycythemia vera, myelofibrosis and overlap syndromes), chronic lymphocytic leukemia, chronic myeloid leukemia)
Rakhi Naik, Johns Hopkins University, Baltimore, MD, United States (Sickle cell disease/trait, Venous thromboembolism, Hematology Education)
Enrico Novelli, University of Pittsburgh, Pittsburgh, PA, United States (Classical Heme)
Sarah O'Brien, Nationwide Children's Hospital, Columbus, OH, United States (Coagulation, Red Cells, Platelets)
James O'Donnell, Royal College of Surgeons in Ireland, Dublin, Ireland (Coagulation and von Willebrand factor)
Kristen O'Dwyer, University of Rochester Medical Center, Rochester, NY, United States (Acute Lymphoblastic Leukemia, Acute Leukemia in Young Adults)
Jamie O'Sullivan, Royal College of Surgeons in Ireland, Dublin, Ireland (FVIII, infection, coagulation)
Anand Patel, The University of Chicago Medicine, Chicago, IL, United States (MDS/MPN/AML)
Naveen Pemmaraju, University of Texas MD Anderson Cancer Center, Houston, TX, United States (MPN, AML, BPDCN)
Miguel Perales, Memorial Sloan Kettering Cancer Center, New York, NY, United States (CAR T cells, Stem cell transplantation, immunotherapy)
Marlien Pieters, North-West University, Potchefstroom, South Africa (Fibrinogen, Fibrin clot properties, Coagulation and epidemiology)
Susan Prockop, Boston Children's Hospital, New York, NY, United States (Viral specific T cells,  Transplant and cell therapy for inborn errors of immunity and autoimmunity)
Muna Qayed, Emory University and Children’s Healthcare of Atlanta, Atlanta, GA, United States (GVHD, CAR-T therapy for ALL, Pediatric transplantation)
Cheng-Kui Qu, Emory University School of Medicine, Atlanta, GA, United States (Hematopoietic stem cell, Leukemic stem cell, Bone marrow microenvironment)
David Ritchie, Royal Melbourne Hospital, Melbourne, Australia (BMT, Translational immunology)
Aldo Roccaro, ASST Spedali Civili di Brescia, Brescia, Italy (Mutiple Myeloma; Waldenstrom's Macroglobulinemia, Tumor microenvironment, Tumor cell-bone marrow niche interactions)
Davide Rossi, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland (Neoplasia, Lymphoid Leukemias)
Lev Silberstein, Fred Hutch Cancer Center and University of Washington, Seattle, WA, United States (Hematopoietic stem cells, Myelodysplasia, Bone marrow microenvironment)
Sonali Smith, The University of Chicago Medicine, Chicago, IL, United States (Lymphoma)
Jacob Soumerai, Massachusetts General Hospital Cancer Center, Boston, MA, United States (Neoplasia/Lymphomas and other Lymphoproliferative Conditions)
Erica Sparkenbaugh, UNC School of Medicine, Chapel Hill, NC, United States (coagulation, sickle cell disease, vascular biology, and inflammation)
Richard Stone, Dana-Farber Cancer Institute, Boston, MA, United States
Paolo Strati, MD Anderson Cancer Center, Houston, TX, United States (Lymphoma, immunotherapy, and CAR T)
Jonathan Strefford, School of Cancer Sciences, University of Southampton, Southampton, UK (B-cell cancers, genomics, epigenetics)
John Strouse, Duke University, Durham, NC, United States (sickle cell disease, iron deficiency anemia, and health services research)
Phil Thompson, Sir Peter MacCallum Cancer Centre, Melbourne, Australia (CLL)
Saad Usmani, Memorial Sloan Kettering Cancer Center, New York, NY, United States (Myeloma/Plasma Cell Disorders, Transplant & Cellular Therapy)
A. Valance Washington, Oakland University, Rochester, MI, United States (Platelets, Immunology)
Matthew Wieduwilt, Wake Forest School of Medicine, Winston-Salem, NC, United States (Acute lymphoblastic leukemia, Acute myeloid leukemia, Hematopoietic cell transplantation)